Business

First Surgical Use of Remplir in US$1.6 Billion US Market

First Surgical Use of Remplir in US$1.6 Billion US Market

Orthocell LtdJune 26, 20254
First Surgical Use of Remplir in US$1.6 Billion US Market

About this update from Orthocell Ltd

Orthocell Ltd has released a press release. View Attachment

View stock analysis, news, and events for Orthocell Ltd

More from Orthocell Ltd

Q4 FY26 ASX Investor Presentation

July 13, 2026

Orthocell Appoints Thailand Distributor for Remplir

July 2, 2026

All Orthocell Ltd news →